Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation? [4]

Pediatric Nephrology

Volumn 22, Issue 1, 2007, Pages 158-160

  Marks, Stephen D ^a   McGraw, Mary ^b  

^a Great Ormond Street Hospital for Children NHS Trust ^*  (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ENALAPRIL; GANCICLOVIR; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; STEROID; TACROLIMUS; VALACICLOVIR; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ALBUMINURIA; CASE REPORT; CHILD; CYTOMEGALOVIRUS INFECTION; DRUG MEGADOSE; DRUG WITHDRAWAL; FOCAL GLOMERULOSCLEROSIS; HUMAN; HYPOALBUMINEMIA; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LAPAROSCOPIC SURGERY; LETTER; MALE; NEPHRECTOMY; NEPHROTIC SYNDROME; NEUTROPENIA; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE;

ANTIBODIES, MONOCLONAL; CHILD; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOLOGIC FACTORS; KIDNEY TRANSPLANTATION; MALE; RECURRENCE;

EID: 33846454668     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0260-x     Document Type: Letter

References (10)

1. Edwards JCW, Cambridge G (2001) Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford) 40(2):205-211
2. Ganne V, Siddiqi N, Kamaplath B, Chang CC, Cohen EP, Bresnahan BA, Hariharan S (2003) Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder. Clin Transplant 17(5):417-422
3. Gorman C, Leandro M, Isenberg D (2003) B cell depletion in autoimmune disease. Arthritis Res Ther 5(Suppl 4):S17-S21
4. Hainsworth JD, Burris HA 3rd, Morrissey LH, Litchy S, Scullin DC Jr, Bearden JD 3rd, Richards P, Greco FA (2000) Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma. Blood 95(10):3052-3056
5. Kazkaz H, Isenberg D (2004) Anti B cell therapy (rituximab) in the treatment of autoimmune diseases. Curr Opin Pharmacol 4(4):398-402
6. Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA (2005) B-cell depletion in the treatment of patients with systemic lupus erythematosus: A longitudinal analysis of 24 patients. Rheumatology (Oxford) 44(12):1542-1545
7. Marks SD, Patey S, Brogan PA, Hasson N, Pilkington C, Woo P, Tullus K (2005) B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus. Arthritis Rheum 52(10):3168-3174
8. Nozu K, Iijima K, Fujisawa M, Nakagawa A, Yoshikawa N, Matsuo M (2005) Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol 20(11):1660-1663
9. Pescovitz MD, Book BK, Sidner RA (2006) Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 354(18):1961-1963
10. Cochat P, Kassir A, Cohen S, Glastre C, Tourniaire B, Parchoux B, Martin X, David L (1993) Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol 7(1):50-54